MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-01-0010557
Ganapati Bio- Tech Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹49.01 Cr
▲ 23% YoY
Net profit · FY 2025
₹32.12 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹1.22 Cr
EBITDA margin 2.5%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹6.87 Lakh
Issued & subscribed
Open charges
₹26.25 Cr
Satisfied ₹2.05 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
12
Provident fund records
About Ganapati Bio- Tech Limited
Data last updated:
Ganapati Bio- Tech Limited is a public limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 February 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PLC065017. Its GSTIN is 07AAACG4685Q1ZY (Delhi).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹6.87 Lakh. It is led by directors including Rameshwar Dayal Goel (Whole-Time Director) and Manoj Kumar Goel (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 22 Main Market Old Rajinder Nagar, New Delhi, Delhi, India – 110060.
As per the financials filed for FY 2025, the company reported a revenue of ₹49.01 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹32.12 Lakh (net margin 0.7%) and EBITDA of ₹1.22 Cr (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 9% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Ganapati Biotech. As per MCA filings, the company has open charges of ₹26.25 Cr and satisfied charges of ₹2.05 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending.
Ganapati Bio- Tech Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0010557). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ganapatibiotechltd.com.
Company details
CIN U74899DL1995PLC065017
Registration Number 065017
Incorporation Date 03 February 1995
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-01-0010557
CIN history
Ganapati Bio- Tech has one previous CIN (Corporate Identification Number): U74899DL1995PTC065017. The current CIN is U74899DL1995PLC065017, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74899DL1995PLC065017 | Current |
| U74899DL1995PTC065017 | Previous |
Key People
Rameshwar Dayal Goel Whole-Time Director Manoj Kumar Goel Whole-Time Director Hardik Goel Director Recognitions & Rankings of Ganapati Bio- Tech
Contact details
Ganapati Bio- Tech Limited's registered office is in New Delhi, Delhi. Its website is ganapatibiotechltd.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No. 22 Main Market Old Rajinder Nagar, New Delhi, Delhi, India – 110060
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ganapati Bio- Tech Limited, buy the company report.
Comprehensive company report
Ganapati Bio- Tech Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Ganapati Bio- Tech operates one associated brand: Ganapati Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Wholesale trading of pharmaceutical and nephrology medicines in New Delhi. | ganapatibiotechltd.com |
Business activity
The main business activity of Ganapati Bio- Tech is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ganapati Bio- Tech Limited, buy the company report.
Financials of Ganapati Bio- Tech Limited
FY 2025 filings availableGanapati Bio- Tech Limited reported revenue of ₹49.01 Cr (up 23% YoY) for FY 2025.
Revenue · FY 2025
₹49.01 Cr ▲ 23%
Net profit · FY 2025
₹32.12 Lakh margin 0.7%
EBITDA · FY 2025
₹1.22 Cr margin 2.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 23%
3 years · compounded
▲ 13%
5 years · compounded
▲ 9%
EBITDA CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 19%
5 years · compounded
▲ 1%
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 23% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.22 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹32.12 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.5% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ganapati Bio- Tech Limited, buy the company report.
Board of directors of Ganapati Bio- Tech Limited
Ganapati Bio- Tech has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hardik Goel Also directs: Mahasu Healthcare LLP | Director | 16 May 2017 | 9 Years 5 Months | Current |
| Rameshwar Dayal Goel | Whole-Time Director | 01 May 2008 | 18 Years 5 Months | Current |
| Sunita Goel Also directs: Dreamskin Essentials Private Limited | Director | 19 Mar 2015 | 11 Years 7 Months | Current |
| Manoj Kumar Goel | Whole-Time Director | 20 May 2002 | 24 Years 5 Months | Current |
Peer comparison
Ganapati Bio- Tech Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sapna Pharmaceuticals Private Limited | ₹49.88 Cr (FY 2024) | 69.0% | Bangalore, Karnataka, India | |||
| Venus Pharmagenerics Private Limited | ₹49.76 Cr (FY 2016) | 7.0% | Solan, Himachal Pradesh, India | |||
| Lazerhead Lifesciences Private Limited | ₹49.03 Cr (FY 2024) | 3005.0% | Telangana, India | |||
| Rena Exports Private Limited | ₹49.02 Cr (FY 2024) | 38.0% | Mumbai, Maharashtra, India | |||
| Ganapati Bio- Tech Limitedthis company | ₹49.01 Cr (FY 2025) | ₹32.12 Lakh | 0.7% | 23.0% | 12 | New Delhi, Delhi, India |
| Pharma Corp. Inc. Private Limited | ₹48.87 Cr (FY 2025) | 10.0% | Indore, Madhya Pradesh, India | |||
| Sundarlal Pharma Distributors Private Limited | ₹48.84 Cr (FY 2025) | 24.0% | Mumbai, Maharashtra, India | |||
| Welcomevet Pharma Private Limited | ₹48.7 Cr (FY 2025) | 4.0% | Lucnow, Uttar Pradesh, India |
To see the full peer comparison of Ganapati Bio- Tech Limited, buy the company report.
Auditor
Ganapati Bio- Tech Limited is audited by M MITTAL AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M MITTAL AND CO | FY 2023 | 003550N |
Shareholding
The shareholding of Ganapati Bio- Tech Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ganapati Bio- Tech Limited, buy the company report.
Charges & borrowings
Open charges
₹26.25 Cr
Satisfied charges
₹2.05 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Mar 2025 | 101097940 | Hdfc Bank Limited | ₹31 Lakh | Open | |
| 28 Apr 2023 | 100713138 | Hdfc Bank Limited | ₹22.56 Lakh | Open | |
| 19 Feb 2022 | 100558809 | Hdfc Bank Limited | ₹15.54 Lakh | Open | |
| 08 Dec 2020 | 100407370 | Hdfc Bank Limited | ₹12.48 Cr | Open | |
| 20 Dec 2019 | 100346223 | Hdfc Bank Limited | ₹12.48 Cr | Open |
To see the full charge records of Ganapati Bio- Tech Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Ganapati Bio- Tech Limited has 2 court cases on record: 1 filed by Ganapati Bio- Tech, 1 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed by the company
1
Filed against the company
1
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 1 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by State Government | Pending |
| District court, Central, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
To see the full case history of Ganapati Bio- Tech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ganapati Bio- Tech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Ganapati Bio- Tech Limited has a workforce of 12 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
12
Active EPFO establishments
1
GST
Ganapati Bio- Tech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACG4685Q1ZY | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ganapati Bio- Tech Limited, buy the company report.
Recent activity
Ganapati Bio- Tech Limited has 9 board changes on record since 2002: 4 appointments and 5 cessations. The latest: Pratibha Goel ceased to be Whole-Time Director on 31 Mar 2021.
AGM
Ganapati Bio- Tech Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 1,248.00 Lakh registered on 08 Dec 2020 with Charge ID 100407370 was modified on 21 Jun 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 1,248.00 Lakh registered on 20 Dec 2019 with Charge ID 100346223 was modified on 21 Jun 2025.
Filing
Ganapati Bio- Tech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 31.00 Lakh with Charge ID 101097940 was registered on 15 Mar 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 22.56 Lakh with Charge ID 100713138 was registered on 28 Apr 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.54 Lakh with Charge ID 100558809 was registered on 19 Feb 2022.
Charges
A charge registered on 23 Mar 2012 via Charge ID 10351723 with Others was fully satisfied on 28 Jul 2021.
Ceased
Pratibha Goel ceased to be Whole-Time Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,248.00 Lakh with Charge ID 100407370 was registered on 08 Dec 2020.
Ceased
Sarita Goel ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,248.00 Lakh with Charge ID 100346223 was registered on 20 Dec 2019.
14 earlier events are in the company report.
Frequently asked questions
Ganapati Bio- Tech is an active public limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 February 1995 (31+ years old) and is registered under CIN U74899DL1995PLC065017.
Ganapati Bio- Tech has 4 current directors:
- Rameshwar Dayal Goel - Whole-Time Director
- Manoj Kumar Goel - Whole-Time Director
- Hardik Goel - Director
- Sunita Goel - Director
The latest financial statements of Ganapati Bio- Tech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ganapati Bio- Tech is 07AAACG4685Q1ZY, registered in Delhi.
The CIN (Corporate Identification Number) of Ganapati Bio- Tech is U74899DL1995PLC065017. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ganapati Bio- Tech has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending.
Ganapati Bio- Tech was incorporated on 03 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ganapati Bio- Tech by revenue are Sapna Pharmaceuticals Private Limited, Venus Pharmagenerics Private Limited, Lazerhead Lifesciences Private Limited, Rena Exports Private Limited, Pharma Corp. Inc. Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Pratibha Goel ceased to be Whole-Time Director on 31 Mar 2021. Sarita Goel ceased to be Director on 31 Mar 2020. Hardik Goel was appointed as Director on 16 May 2017. Ganapati Bio- Tech has 9 board changes on record in total.
Yes, Ganapati Bio- Tech is registered as a small enterprise under Udyam registration (number: UDYAM-DL-01-0010557).
Ganapati Bio- Tech can be reached through the website ganapatibiotechltd.com. Its registered office is in New Delhi, Delhi, India.